BIOMAT Database Logo BIOMAT Database Logo

[Growth Hormone (GH) treatment in GH deficient children]. 2003

Toshiaki Tanaka
Division of Endocrinology and Metabolism, National Center for Child Health and Development.

Bone mineral density (BMD) is reduced in children with growth hormone deficiency. Long-term GH therapy has been shown to increase BMD and levels of biochemical markers of bone turnovre. Adequate GH replacement therapy should be performed, starting as early as possible and optimizing treatment with adequate dose to achieve normal BMD at the time of reaching final height.

UI MeSH Term Description Entries

Related Publications

Toshiaki Tanaka
Growth hormone treatment in non-classical GH deficient children.
January 1989, Journal of endocrinological investigation,
Toshiaki Tanaka
Effectiveness of growth hormone (GH) therapy in GH-deficient children and non-GH-deficient short children.
April 1988, European journal of pediatrics,
Toshiaki Tanaka
Does growth hormone (GH) enhance growth in GH-deficient children with myelomeningocele?
August 2000, The Journal of clinical endocrinology and metabolism,
Toshiaki Tanaka
Growth hormone (GH) treatment in non-GH deficient chronic disease.
October 1998, Journal of the American College of Nutrition,
Toshiaki Tanaka
Growth hormone (GH) responses to GH-releasing peptide and to GH-releasing hormone in GH-deficient children.
May 1995, The Journal of clinical endocrinology and metabolism,
Toshiaki Tanaka
Combined bromocriptine and growth hormone (GH) treatment in GH-deficient children with macroprolactinoma in situ.
July 1992, The Journal of clinical endocrinology and metabolism,
Toshiaki Tanaka
Non-growth hormone (GH) deficient short children--what role for GH?
January 1997, Journal of pediatric endocrinology & metabolism : JPEM,
Toshiaki Tanaka
Corticoid-induced growth hormone (GH) secretion in GH-deficient and normal children.
August 1992, The Journal of clinical endocrinology and metabolism,
Toshiaki Tanaka
Therapeutic controversies: growth hormone (GH) treatment of non-GH deficient subjects.
November 1994, The Journal of clinical endocrinology and metabolism,
Toshiaki Tanaka
Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults.
February 1999, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!